Aferian PLC Reports 36% Revenue Growth and Swing to Profit in H1 FY2025
Aferian PLC reports 36% H1 revenue surge to $16.6m & swings to profit (Adjusted EBITDA $1.6m-$1.8m). Amino division rockets 94% as turnaround accelerates.
This article covers information on Aferian PLC.
LON:AFRNAferian’s H1 Surge: From Red Ink to Streaming Profits
Right, let’s dive into this update from Aferian (AIM: AFRN), because frankly, it’s the kind of turnaround story that makes you sit up and take notice. After navigating some choppy waters, the B2B video streaming specialist appears to have found its footing – and then some. Their H1 FY2025 trading update screams positive momentum.
The Headline Act: Serious Growth & Profitability Returns
Forget marginal improvements; Aferian’s swinging for the fences. They’re expecting $16.6 million in revenue for the six months ended 31 May 2025. That’s a hefty 36% jump compared to the same period last year (H1 FY2024: $12.2m).
But the real showstopper? The dramatic flip in profitability. Gone is the Adjusted EBITDA loss of $2.3 million from H1 last year. Instead, they’re anticipating Adjusted EBITDA in the $1.6m to $1.8m range. That’s not just breaking even; that’s generating solid cash flow from operations. This swing underscores the impact of their cost restructuring and suggests their core business is firing much more efficiently.
Drilling Down: Where’s the Growth Coming From?
Not all divisions are singing from the same hymn sheet just yet, but the lead vocalist is clear:
- Amino (Connecting Pay TV to Streaming): This is the powerhouse performance. Amino revenue is expected to hit $9.3m, a frankly astonishing 94% increase year-on-year (H1 FY2024: $4.8m). The driver? Strong, repeat orders from their existing Pay TV customer base. Clearly, their proposition of bridging traditional TV and streaming services is resonating strongly.
- 24i (Streaming Video Experiences): Holding steady at $7.3m, essentially flat versus H1 FY2024. The RNS notes customer churn was offset by new customer wins. It’s stable, but the explosive growth seen at Amino hasn’t materialised here yet. One to watch for signs of acceleration.
Debt, Liquidity, and the Refinancing Watch
It’s not all champagne and caviar just yet. Net debt stands at $14.2m as of 31 May 2025. While slightly down from $14.9m a year prior, it’s up from $12.7m at the FY2024 year-end (Nov 2024). The company attributes this to normal seasonal working capital movements.
The key takeaway here is the ongoing refinancing discussions. Management explicitly states they are prioritising working capital optimisation and cost control while these talks progress. An update is promised “in due course.” Successfully navigating this refinancing will be crucial for underpinning their recovery and funding future growth. It’s the lingering subplot investors will be tracking closely.
CEO Confidence & The Outlook: Growth Trajectory Intact
CEO Mark Carlisle isn’t mincing words. He frames H1 FY2025 as a continuation of the “strong turnaround performance” seen in H2 last year. Crucially, he expects this level of profitability to continue into H2 FY2025.
The guidance is bold: full-year revenues are expected to be approximately 20% higher than FY2024, driven predominantly by that surging Amino business. If they deliver on this, coupled with sustained profitability, it paints a compelling picture of a company firmly back on track.
The Bottom Line: A Phoenix Rising?
This H1 update from Aferian is undeniably positive. A 36% revenue surge combined with a swing from significant loss to meaningful profit isn’t just a good half-year; it’s a potential inflection point. The Amino division is proving to be a stellar performer, validating its strategic focus.
Challenges remain, primarily the debt load and the need to successfully conclude refinancing. The flat performance at 24i, while stable, needs to find a growth gear to match its sibling.
However, the confidence emanating from management, backed by these hard numbers, suggests Aferian has executed its turnaround plan effectively. They’ve stemmed the losses and ignited growth. If they can lock in that refinancing and maintain Amino’s momentum, the story evolving at Aferian could be one of the more interesting tech turnarounds on AIM. One to keep firmly on the watchlist ahead of those interim results in August.
Related
Keep reading
Investing
AstraZeneca’s Enhertu delivers Phase III lung cancer PFS win
Enhertu delayed disease progression versus standard care in a Phase III lung cancer trial, supporting its potential move into first-line treatment.
JoshuaAugust 17, 2026
Investing
Optima Health FY26 results: growth beats expectations as PAM integration begins
Optima Health beat adjusted EBITDA expectations in FY26, while the £100 million PAM acquisition reshaped its growth prospects and balance sheet.
JoshuaAugust 17, 2026
Investing
Nostrum Oil & Gas Agrees $304.6 Million Kazakhstan Sale Ahead of Wind-Down
Nostrum plans to sell its Kazakhstan operations, repay secured notes in full and begin an orderly wind-down after completion.
JoshuaAugust 17, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.